Jan 4, 2026 · Denosumab is a human monoclonal antibody that works by inhibiting RANKL (receptor activator of nuclear factor kappa-B ligand), a protein essential for osteoclasts' …

Jul 3, 2024 · Find patient medical information for Denosumab (Prolia, Jubbonti, Stoboclo) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user …

Denosumab inhibits this maturation of osteoclasts by binding to and inhibiting RANKL. Denosumab mimics the natural action of osteoprotegerin, an endogenous RANKL inhibitor, …

Jan 1, 2026 · Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in men. It is given …

This page contains brief information about denosumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Denosumab is a lab-made human monoclonal immunoglobulin G2 (IgG2) antibody medication used to reduce bone loss in patients at high risk for bone fractures due to postmenopausal …

Prolia® injection is a brand of denosumab, which treats osteoporosis. Osteoporosis is a condition that weakens your bones, making them more susceptible to fractures.

Denosumab injection is in a class of medications called RANK ligand inhibitors. It works to prevent bone loss by blocking a certain receptor in the body to decrease bone breakdown.

Denosumab (Prolia) is a biologic medication used to prevent fragile bones, also known as osteoporosis, and bone fractures. See how to take it and side effects.

Denosumab, a bone anti-resorptive medication, treats osteoporosis and various bone-related disorders.